Comments on "Analysis of 50 SNPs in CYP2D6, CYP2C19, CYP2C9, CYP3A4 and CYP1A2 by MALDI-TOF mass spectrometry in Chinese Han population"

被引：1
|
作者：
Gesteira Ponce, Alejandro [1 ]
机构：
[1] Fdn Publ Galega Med Xenom SERGAS, Santiago De Compostela, Spain
来源：
FORENSIC SCIENCE INTERNATIONAL | 2011年 / 211卷 / 1-3期
关键词：
COPY NUMBER;
D O I：
10.1016/j.forsciint.2011.04.001
中图分类号：
DF [法律]; D9 [法律]; R [医药、卫生];
学科分类号：
0301 ; 10 ;
摘要：
引用
收藏
页码：E7 / E8
页数：2
相关论文
共 50 条
  • [21] Genetic and phenotypic frequency distribution of CYP2C9, CYP2C19 and CYP2D6 in over 3200 Han Chinese
    He, Li
    Chen, Shaojun
    Li, Jingao
    Xie, Xiaoxue
    Huang, Lihua
    Kuang, Yun
    Xu, Kangwei
    Huang, Wanxia
    Zhao, Yanling
    Yang, Guoping
    Guo, Chengxian
    CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY, 2020, 47 (10) : 1659 - 1663
  • [22] Effects of Panax notoginseng Saponins on the Activities of CYP1A2, CYP2C9, CYP2D6 and CYP3A4 in Rats In Vivo
    Liu, Rui
    Qin, Mengnan
    Hang, Pengzhou
    Liu, Yan
    Zhang, Zhiren
    Liu, Gaofeng
    PHYTOTHERAPY RESEARCH, 2012, 26 (08) : 1113 - 1118
  • [23] Combination Analysis in Genetic Polymorphisms of Drug-Metabolizing Enzymes CYP1A2, CYP2C9, CYP2C19, CYP2D6 and CYP3A5 in the Japanese Population
    Ota, Tomoko
    Kamada, Yuka
    Hayashida, Mariko
    Iwao-Koizumi, Kyoko
    Murata, Shigenori
    Kinoshita, Kenji
    INTERNATIONAL JOURNAL OF MEDICAL SCIENCES, 2015, 12 (01): : 78 - 82
  • [24] Effects of H2S on the Activities of CYP2B6, CYP2D6, CYP3A4, CYP2C19 and CYP2C9 in Vivo in Rat
    Wang, Xianqin
    Han, Anyue
    Wen, Congcong
    Chen, Mengchun
    Chen, Xinxin
    Yang, Xuezhi
    Ma, Jianshe
    Lin, Guanyang
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2013, 14 (12): : 24055 - 24063
  • [25] CYP2D6, CYP2C19 AND CYP2C9 GENOTYPING IN A SWEDISH CLINICAL SETTING
    Scordo, M. G.
    CLINICAL THERAPEUTICS, 2015, 37 (08) : E9 - E9
  • [26] Effects of polymorphisms in CYP2D6, CYP2C9, and CYP2C19 on trimipramine pharmacokinetics
    Kirchheiner, J
    Müller, G
    Meineke, I
    Wernecke, KD
    Roots, I
    Brockmöller, J
    JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 2003, 23 (05) : 459 - 466
  • [27] REVERSIBLE AND TIME-DEPENDENT INHIBITION (TDI) OF CYP1A2, CYP2B6, CYP2C8, CYP2C9, CYP2C19, CYP2D6 AND CYP3A4 IN HUMAN HEPATOCYTE SUSPENSIONS BY MODEL INHIBITORS
    Zhang, J. George
    Thuy Ho
    Patel, Reena
    Trisdale, Sarah K.
    Creegan, Tim
    Stresser, David M.
    DRUG METABOLISM AND PHARMACOKINETICS, 2017, 32 (01) : S57 - S58
  • [28] Pharmacokinetics of CYP2C9, CYP2C19, and CYP2D6 substrates in healthy Chinese and European subjects
    Lu, Sijie
    Nand, R. A.
    Yang, J. S.
    Chen, Gang
    Gross, A. S.
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2018, 74 (03) : 285 - 296
  • [29] Pharmacokinetics of CYP2C9, CYP2C19, and CYP2D6 substrates in healthy Chinese and European subjects
    Sijie Lu
    R. A. Nand
    J. S. Yang
    Gang Chen
    A. S. Gross
    European Journal of Clinical Pharmacology, 2018, 74 : 285 - 296
  • [30] Dicloxacillin induces CYP2C19, CYP2C9 and CYP3A4 in vivo and in vitro
    Stage, Tore Bjerregaard
    Graff, Magnus
    Wong, Susan
    Rasmussen, Louise Ladebo
    Nielsen, Flemming
    Pottegard, Anton
    Brosen, Kim
    Kroetz, Deanna L.
    Khojasteh, Cyrus
    Damkier, Per
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2018, 84 (03) : 510 - 519
12345